![]() |
![]() |
| Abstract | 99. Jahrestagung der DOG, 29. 9. - 2. 10. 01 im ICC, Berlin |
Anmeldung zur Tagung Registration Grußwort Invitation Themen Topics Allgemeiner Ablauf General overview Wissenschaftliches Programm Scientific program Kurse Courses Symposien Symposiums Frühstück mit Spezialisten Breakfast with specialists Arzthelferinnen-Fortbildung Rahmenprogramm Social program DOG Information DOG Information Allgemeine Informationen General Information Autorenindex Index of Authors Ausstellerliste Exhibitors Sponsoren Sponsors Teilnahmegebühren Registration fees Impressum |
|
| In vitro results about the use of CD95 ligand as an apoptotic inductor in glaucomatous filtering procedures 1Hueber A., 1Welsandt G., 1Mietz H., 1Jordan J. F., 2Weller M., 1Esser P. J. 1Zentrum für Augenheilkunde der Universität zu Köln, Joseph-Stelzmann-Str. 9, 50931 Köln, Deutschland; 2Neurologische Klinik, Eberhard-Karls-Universität Tübingen, Hoppe-Seyler-Str. 3, 72076 Tübingen Objective: Apoptosis allows for the safe disposal of cells without
damaging the surrounding tissue. It is a morphologically defined type
of cell death that is commonly observed during development, e.g., in the
immune and central nervous system and is often referred to as programmed
or physiological cell deaths. Unspecific toxic side effects by the use
of antimetabolites (e.g. 5-fluorouracil or mitomycin-C) in glaucomatous
filtering procedures may be eliminated by induction of apoptosis by CD95
ligand. |
|
| DOG Homepage | Zurück / Back |
|
|
|